Pancragen — Benefits, Dosage & Where to Buy
Research Overview
Pancragen is a synthetic tetrapeptide bioregulator targeting pancreatic tissue. Developed by Dr. Khavinson, it modulates gene expression in pancreatic cells and has been studied for improving insulin secretion and pancreatic function in diabetes and age-related metabolic decline.
In clinical studies, Pancragen improved glucose metabolism parameters and insulin sensitivity in patients with type 2 diabetes when used as adjunctive therapy.
Key Research Findings
- •Improved insulin secretion in pancreatic beta cell models
- •Enhanced glucose metabolism in type 2 diabetes patients as adjunctive therapy
- •Modulated gene expression in pancreatic tissue
- •Promoted pancreatic cell survival under metabolic stress
Research Dosage Protocols
Administered in 10-day courses of 10 mg daily via intramuscular injection, repeated 2-3 times annually.
For research reference only. Not medical advice. Not for human consumption.
Price Comparison (7 products from 7 vendors)
| Vendor | Price | Stock |
|---|---|---|
| Swiss Chems | $59.95 $3.00/mg 20mg vial | In Stock |
| Pure Rawz | $61.78 $3.09/mg 20mg vial | In Stock |
| Core Peptides | $63.00 $3.15/mg 20mg vial | In Stock |
| Soma Chems | $64.99 $3.25/mg 20mg vial | In Stock |
| Peptide Sciences | $65.00 $3.25/mg 20mg lyophilized | In Stock |
| Limitless Biotech | $65.00 $3.25/mg 20mg lyophilized | Out |
| BioLongevity Labs | $94.97 $4.75/mg 20mg vial | In Stock |
Frequently Asked Questions
What is Pancragen?
Pancragen is a synthetic tetrapeptide (Lys-Glu-Asp-Trp) developed by Professor Vladimir Khavinson as a bioregulator targeting pancreatic tissue. It is researched for its effects on insulin secretion, glucose metabolism, and pancreatic beta-cell gene expression. It is part of the Khavinson bioregulator peptide family.
What is Pancragen researched for?
Pancragen is studied for pancreatic function, insulin secretion modulation, glucose metabolism improvement, and beta-cell survival. Research has examined its effects on gene expression in pancreatic tissue and its potential role in metabolic health and diabetes models.
How does Pancragen compare to semaglutide for metabolic research?
They work through completely different mechanisms. Semaglutide is a GLP-1 receptor agonist that mimics incretin hormones to regulate blood sugar and appetite. Pancragen is a bioregulator peptide that targets pancreatic gene expression directly. Semaglutide has extensive FDA-approved clinical data; Pancragen's research is primarily from Russian bioregulator studies.
Where can I buy Pancragen?
Pancragen is available from multiple research peptide vendors at $2.99 to $4.75 per milligram. See the price comparison table above for current pricing and stock availability across vendors.
What is the standard Pancragen research protocol?
Following the Khavinson bioregulator protocol, Pancragen is typically dosed at 10mg daily for 10-day courses, administered intramuscularly, repeated 2-3 times per year.